Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
Date:5/9/2013

t 8:00 p.m. Beijing/Hong Kong time). The management team will be on the call to discuss the results for the first quarter of 2013 and to answer questions.

To access the conference call, please dial:International toll:

+65.6723.9381United States toll-free:

+1.866.519.4004United States toll:

+1.718.354.1231China Domestic toll:

800.819.0121 China Domestic mobile toll:

400.620.8038 Hong Kong toll:

+852.2475.0994Please ask to be connected to Q1 2013 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 58031483.

Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:United States toll-free:

+1. 855.452.5696United States toll:

+1. 646.254.3697The passcode for replay participants is 58031483. The telephone replay also will be archived on the "Investor Relations" section of the company's web site for seven days following the earnings announcement.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.Investor and Media Contacts: Email:

SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
2. Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
3. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
4. Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
5. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Legal Counsel
6. Simcere Pharmaceutical Group Announces Receipt of "Going Private" Proposal
7. Simcere Pharmaceutical Group Reports Preliminary Unaudited Fourth Quarter And Full Year 2012 Results
8. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013
9. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
11. Simcere Pharmaceutical Group to Announce Third Quarter 2012 Financial Results on Thursday, November 15, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014 Scott Steiger ... most of the world. As an engineer for the past 20 ... member of the military service. He,s been to six of the ... Photo - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... for travelers, he has a pretty good idea of what,s required. ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
(Date:11/26/2014)... , Nov. 26, 2014 The ... at a rate of 4%, with world market ... Kalorama Information. MRI and other types of medical ... and treatment of numerous medical conditions in children ... and techniques. Kalorama,s report, Medical Imaging Markets ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
... , , SEATTLE, Dec. 9 Omeros Corporation today ... to serve on the Company,s Board. Mr. Spiegelman has also been ... are very pleased to welcome Dan to our Board and look ... CEO of Omeros. "Dan brings a substantial depth and breadth of ...
... , WALTHAM, Mass., Dec. 9 Decision ... focusing on pharmaceutical and healthcare issues, finds that compared to ... are being used more often to treat newly diagnosed patients ... second-line patients received a TNF-alpha inhibitor versus one year ago ...
Cached Medicine Technology:Daniel K. Spiegelman Elected to Board of Directors of Omeros 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3
(Date:11/28/2014)... Recently, BellasDress , a renowned dress manufacturer in the ... of cocktail dresses. In addition, these fresh dresses are available ... shipping on orders over $179. The aim of the special ... providing many styles of dresses, which come in various colors; ... more. All of them are on sale at affordable prices. ...
(Date:11/28/2014)... November 29, 2014 Recently, SWAccessControl.com, a ... systems. At the moment, all these high end products ... off. The special offer will last from today to ... “We are happy to launch the promotion. We are ... worldwide distributors with the latest information about our hottest ...
(Date:11/28/2014)... Recently, PrettyTailor.com has developed and created its new collection ... world in celebration of the coming holiday season. To ... special offer on all these outfits. Click here ... the garment industry, PrettyTailor.com brings together art and technology ... The business carries quite a few in eye-catching patterns ...
(Date:11/28/2014)... The month of December has the highest ... occurring in Florida every year in December , attorney Sean ... insurance policies. , "Optional auto insurance coverage is something you ... cheap I know, actually Florida is among the states, where ... but what I see is that the insurance required by ...
(Date:11/28/2014)... News) -- People with diabetes face a number of challenges ... healthy, an expert says. "With the holidays coming, take ... events, the family you,ll be visiting and all of the ... Educators, said in an association news release. "By planning ahead. ... One idea is to make a healthy eating contract with ...
Breaking Medicine News(10 mins):Health News:BellasDress Offers A Big Surprise By Updating Its Cheap and Charming Cocktail Dresses 2Health News:New Access Control Systems Now Offered At Low Prices By Smartware Manufacturer SWAccessControl.com 2Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Car Accident Attorney Sean M. Cleary on Auto Insurance Policies Essential for Florida Drivers 2Health News:Holiday Eating Tips for People With Diabetes 2
... sedimentation rate (ESR) increases during pregnancy. Also, both ... ,The erythrocyte sedimentation rate is one of ... is helpful in detecting the presence of inflammation ... by anaemia, which may be present in inflammatory ...
... to be in critical condition in a hospital here where ... government said. // ,Narayanan, who turned 85 ... and Referral Hospital two days later and has been on ... his condition. He continues to be critical, the aide said. ...
... are now produced which has been found to have ... Immunotherapy vaccines. //Antibodies against the allergen is given as ... allergen or infection these antibodies which are already present ... ,Conventional antibody injections against allergy diseases such ...
... the November issue of the Journal of the National Cancer ... after treatment, and patients treated with the higher chemotherapy dose ... ,Germ-cell testicular cancer is the most common cancer among 20-40 ... an age at which they are starting a family, and ...
... is a FDA approved long-term treatment regime for patients ... therapy is now being offered to patients at NewYork-Presbyterian ... now the first treatment specifically approved for TRD in ... therapy has been unsuccessful atleast in four or more ...
... cancer does not mean that you can cool your heels, ... experts have warned people. // ,These warnings were ... by eminent doctors who took part in a panel discussion ... In a keynote address delivered on the occasion, Prof D ...
Cached Medicine News:Health News:Oral Edible vaccine for Allergy Vaccines 2Health News:Decline in Paternity Rates Following Treatment for Testicular Cancer 2Health News:FDA Approved Nerve-Stimulation Therapy Now Available In New York 2
... Infinity Triglycerides powder reagent once reconstituted ... of single liquid stability to help ... and provide quick result turnaround time. ... Triglycerides powder reagent provides a long ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The patented ... provides a long shelf life that ...
... Infinity Creatinine single liquid stable reagent ... of single liquid stability to help ... and provide quick result turnaround time. ... Creatinine reagent provides a long shelf ...
... Amylase powder reagent once reconstituted offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... powder reagent provides a long shelf ...
Medicine Products: